CRSP 250509 40.50P(CRSP250509P40500) Stock Price Today

US OptionsDetailed Quotes

CRSP250509P40500

Watchlist

3.25
0.000.00%

15min DelayClose May 9 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Illinois Tool Works, Wynn Resorts, Agree Realty, Crispr Therapeutics, Super Micro Computer: Trending by Analysts
TipRanks05:01 ET · Ratings
Crispr Therapeutics Is Maintained at Equal-Weight by Barclays
Dow JonesMay 9 09:24 ET · Ratings
Crispr Therapeutics Price Target Cut to $42.00/Share From $56.00 by Barclays
Dow JonesMay 9 09:24 ET · Ratings
Barclays Maintains CRISPR Therapeutics(CRSP.US) With Hold Rating, Cuts Target Price to $42
Moomoo NewsMay 9 08:31 ET · Ratings
Express News | CRISPR Therapeutics AG : Barclays Cuts Target Price to $42 From $56
ReutersMay 9 05:41 ET
Truist Financial Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating
Moomoo NewsMay 9 03:34 ET · Ratings

Comments

YouliHawaii

May 7 00:15

$CRISPR Therapeutics (CRSP.US)$ 🙏

103288307

May 6 22:21

$CRISPR Therapeutics (CRSP.US)$ when you wake up brother, can give a nice results or not

Aurum_ai

Apr 17 23:12

Hidden Gems 隐藏的宝石

Small and mid-cap companies with the potential to replicate the success of large-cap giants like $Apple (AAPL.US)$ , $Amazon (AMZN.US)$ , $NVIDIA (NVDA.US)$, $Alphabet-A (GOOGL.US)$, $Meta Platforms (META.US)$, $Microsoft (MSFT.US)$ and $Tesla (TSLA.US)$ often operate in high-growth industries such as cloud computing, AI, electric vehicles (EVs), and clean energy.
For example, companies like $Zscaler (ZS.US)$ and $Datadog (DDOG.US)$ are leaders in cloud-based cybersecurity and monitorin...

70107480

Apr 4 23:51

$CRISPR Therapeutics (CRSP.US)$
This tariffs move is affecting everything, as per Trump interview yesterday, one News Anchor ask about when does Trump expect the economy to recover, he said about 2 years…. We might expect more Red this year, hope the market will recover sooner.

PhotoSynth

Apr 3 06:21

Thank God CRSP has no real exposure to these blithering tariffs. All the way down here…… I’m definitely a Buyer

$CRISPR Therapeutics (CRSP.US)$